Literature DB >> 10781517

T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy.

A Pappa1, J M Lawson, V Calder, P Fells, S Lightman.   

Abstract

AIM: To determine whether there are differences in the lymphocytic cell infiltrate present in affected extraocular muscles (EOM) during early and late stages of thyroid associated ophthalmopathy (TAO).
METHODS: 17 biopsies of affected EOMs were collected from two groups of TAO patients (n=14): the first of five patients with early, active TAO, and the second of nine patients with late, inactive TAO. The control group was of EOM biopsies taken from 14 non-TAO patients undergoing squint surgery. Immunohistochemical analysis was undertaken using the relevant monoclonal antibodies and an avidin-biotin system and the three groups compared.
RESULTS: Both CD4+ and CD8+ T cells were found in the cellular infiltrate in early, active TAO specimens which were much less evident either in late, inactive stage disease or in control tissue. There was also a significant increase in both CD45RO+ and CD45RB+ cells and macrophages in early TAO compared with the others. Increased expression of HLA-DR antigen by interstitial cells including fibroblasts was detected in both early and late disease but the EOM fibres remained morphologically intact and did not express MHC class II antigens at any time.
CONCLUSION: These results demonstrate that T cells are only significantly present in early disease but increased HLA-DR antigen expression on fibroblasts is observed at all stages. This suggests that T cells are much more involved in the early than the later stages of the disease process and that early activation of fibroblasts occurs. Early intervention with immunosuppressive therapy to downregulate cytokine production by T cells may significantly influence the sequelae caused by EOM fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781517      PMCID: PMC1723449          DOI: 10.1136/bjo.84.5.517

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  27 in total

1.  Immunohistochemical staining of normal and Graves' extraocular muscle.

Authors:  L Tallstedt; R Norberg
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-02       Impact factor: 4.799

2.  Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.

Authors:  A P Weetman; S Cohen; K C Gatter; P Fells; B Shine
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

3.  Modification of the classification of the eye changes of Graves' disease.

Authors:  S C Werner
Journal:  Am J Ophthalmol       Date:  1977-05       Impact factor: 5.258

Review 4.  Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.

Authors:  D H Jacobson; C A Gorman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

Review 5.  Graves' ophthalmopathy: what is the evidence for extraocular muscle specific autoantibodies.

Authors:  R van der Gaag; R Vernimmen; N Fiebelkorn; M C van Dierendonck; A Kijlstra
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

6.  Appearance of Graves' disease on orbital computed tomography.

Authors:  D R Enzmann; S S Donaldson; J P Kriss
Journal:  J Comput Assist Tomogr       Date:  1979-12       Impact factor: 1.826

7.  Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease.

Authors:  T J Hufnagel; W F Hickey; W H Cobbs; F A Jakobiec; T Iwamoto; R C Eagle
Journal:  Ophthalmology       Date:  1984-11       Impact factor: 12.079

8.  Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.

Authors:  T Hanafusa; R Pujol-Borrell; L Chiovato; R C Russell; D Doniach; G F Bottazzo
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

9.  Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroid.

Authors:  M Bagnasco; D Venuti; I Prigione; G C Torre; S Ferrini; G W Canonica
Journal:  Clin Immunol Immunopathol       Date:  1988-05

10.  Graves' ophthalmopathy. A clinical and immunologic review.

Authors:  R C Sergott; J S Glaser
Journal:  Surv Ophthalmol       Date:  1981 Jul-Aug       Impact factor: 6.048

View more
  23 in total

1.  Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression.

Authors:  A K Eckstein; B Quadbeck; S Tews; K Mann; C Krüger; C H Mohr; K-P Steuhl; J Esser; R K Gieseler
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

Review 2.  Recent developments in thyroid eye disease.

Authors:  Tom Cawood; Paul Moriarty; Donal O'Shea
Journal:  BMJ       Date:  2004-08-14

Review 3.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

Review 4.  Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy.

Authors:  Y P Hai; A C H Lee; L Frommer; T Diana; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2019-09-19       Impact factor: 4.256

Review 5.  Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.

Authors:  Seethalakshmi Iyer; Rebecca Bahn
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

6.  Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes.

Authors:  Steven E Feldon; Charles W O'loughlin; Denise M Ray; Shira Landskroner-Eiger; Kathryn E Seweryniak; Richard P Phipps
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

Review 7.  2021 update on thyroid-associated ophthalmopathy.

Authors:  E J Neag; T J Smith
Journal:  J Endocrinol Invest       Date:  2021-08-20       Impact factor: 5.467

8.  Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?

Authors:  Hooshang Lahooti; Kishan R Parmar; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2010-05-14

9.  [Octreotide scintigraphy for the diagnosis of active Graves' ophthalmopathy].

Authors:  N Ardjomand; G Esche; P Fellner; S Lindner; M Panzitt; R Aigner; A Langmann
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

10.  Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy.

Authors:  Giovanna Rotondo Dottore; Liborio Torregrossa; Patrizio Caturegli; Ilaria Ionni; Angela Sframeli; Elena Sabini; Francesca Menconi; Paolo Piaggi; Stefano Sellari-Franceschini; Marco Nardi; Francesco Latrofa; Paolo Vitti; Claudio Marcocci; Fulvio Basolo; Michele Marinò
Journal:  JAMA Ophthalmol       Date:  2018-06-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.